Since we have revealed that the expression of CDK1 and iASPP at mRNA and protein levels were both increased in tumor tissues; suppressing CDK1 and iASPP expression in tumor tissues present a promising strategy for CRC treatment. Here, CDK1 is linked to colorectal carcinoma.